VanEck Pharmaceutical ETF
PPH
PPH
124 hedge funds and large institutions have $668M invested in VanEck Pharmaceutical ETF in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
-8
Holders Change %
-6.06%
% of All Funds
1.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
18
Increased
38
Reduced
41
Closed
23
Calls
$3.32M
Puts
$41.4M
Net Calls
-$38.1M
Net Calls Change
+$24.9M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$141M |
| 2 |
Morgan Stanley
New York
|
+$39.3M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$35.4M |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$28.6M |
| 5 |
Jane Street
New York
|
+$23.8M |
Top Sellers
| 1 |
Fisher Asset Management
Camas,
Washington
|
-$111M |
| 2 |
QC
Quadrature Capital
London,
United Kingdom
|
-$12.4M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$10.4M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.13M |
| 5 |
Two Sigma Investments
New York
|
-$4.6M |
